M R Jacobs - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M R Jacobs

Showing results (81-90 of 264) with videos related to

Pageof 27

Sort By:

Pediatric Infectious Disease|November 1, 1985

Chromobacterium violaceum adenitis acquired in the northern United States as a complication of chronic granulomatous diseaseR U Sorensen, M R Jacobs, S B Shurin

Antimicrobial Agents and Chemotherapy|September 16, 1998

Activities of gatifloxacin compared to those of seven other agents against anaerobic organismsL M Ednie, M R Jacobs, P C Appelbaum

Journal of Clinical Microbiology|November 18, 1998

Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologiesC L Clark, M R Jacobs, P C Appelbaum

Antimicrobial Agents and Chemotherapy|February 1, 1996

MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciM A Visalli, M R Jacobs, P C Appelbaum

Antimicrobial Agents and Chemotherapy|February 1, 1996

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990

Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazoleM R Jacobs, S K Spangler, P C Appelbaum

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993

Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum

Antimicrobial Agents and Chemotherapy|April 1, 1994

Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycinS K Spangler, M R Jacobs, P C Appelbaum

Antimicrobial Agents and Chemotherapy|September 3, 1999

Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are highC L Clark, M R Jacobs, P C Appelbaum

Diagnostic Microbiology and Infectious Disease|December 8, 2000

Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazoleK L Credito, M R Jacobs, P C Appelbaum

Pageof 27

Search research articles

Showing results (81-90 of 264) with videos related to

Sort By:

Pageof 27

Pediatric Infectious Disease|November 1, 1985

Chromobacterium violaceum adenitis acquired in the northern United States as a complication of chronic granulomatous diseaseR U Sorensen, M R Jacobs, S B Shurin

Antimicrobial Agents and Chemotherapy|September 16, 1998

Activities of gatifloxacin compared to those of seven other agents against anaerobic organismsL M Ednie, M R Jacobs, P C Appelbaum

Journal of Clinical Microbiology|November 18, 1998

Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologiesC L Clark, M R Jacobs, P C Appelbaum

Antimicrobial Agents and Chemotherapy|February 1, 1996

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993

Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum

Antimicrobial Agents and Chemotherapy|April 1, 1994

Antimicrobial Agents and Chemotherapy|September 3, 1999

Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are highC L Clark, M R Jacobs, P C Appelbaum

Diagnostic Microbiology and Infectious Disease|December 8, 2000

Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazoleK L Credito, M R Jacobs, P C Appelbaum

Pageof 27